Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$62,457,944
-$37,320,921 QoQ
Shares Held
1,147,913
-50.7% QoQ
Ownership
0.463%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,908,415,112 across 370 Biotechnology names. EXEL ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,457,944 | 1,147,913 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $99,778,865 | 2,326,390 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $94,655,398 | 2,159,603 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $73,737,556 | 1,785,413 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $119,029,971 | 2,700,317 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $88,331,726 | 2,392,517 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $98,155,043 | 2,947,599 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $63,890,767 | 2,462,072 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $52,164,193 | 2,321,504 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $46,568,152 | 1,962,417 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $73,697,734 | 3,072,019 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $63,024,662 | 2,884,424 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $50,408,719 | 2,637,819 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $115,914,557 | 5,971,899 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $209,324,853 | 13,050,178 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $244,256,296 | 15,577,570 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $362,211,492 | 17,397,286 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $389,924,724 | 17,200,032 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $343,755,033 | 18,804,980 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $397,717,007 | 18,813,482 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $366,250,932 | 20,101,588 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $342,410,363 | 15,157,608 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $255,893,923 | 12,750,071 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $303,512,250 | 12,413,589 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $96,588,373 | 4,068,592 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $99,770,785 | 5,793,890 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||